Content area
Abstract
Newer Biologic and Small-Molecule Therapies for IBD
There is still no cure for inflammatory bowel disease. This review covers newer treatments that reflect our understanding of the complex pathogenesis of IBD, with a focus on clinical and endoscopic remission and more precise molecular targeting of inflammatory cascades.
Details

1 From the Division of Gastroenterology, University of Alberta, Edmonton, Canada (D.C.B.); and Institut des Maladies de l’Appareil Digestif, Nantes University Hospital, Nantes, and the Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, Vandœuvre-lès-Nancy — both in France (C.L.B.).